首页|期刊导航|中国肺癌杂志|Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations

Guowei ZHANG Ruirui CHENG Yuanyuan NIU Huijuan WANG Xiangtao YAN Mina ZHANG Xiaojuan ZHANG Jinpo YANG Chunhua WEI Zhiyong MA

中国肺癌杂志2022，Vol.25Issue(9)：P.651-657,7.

中国肺癌杂志2022，Vol.25Issue(9)：P.651-657,7.DOI:10.3779/j.issn.1009-3419.2022.102.34

Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations

Guowei ZHANG ¹Ruirui CHENG ²Yuanyuan NIU ¹Huijuan WANG ¹Xiangtao YAN ¹Mina ZHANG ¹Xiaojuan ZHANG ¹Jinpo YANG ¹Chunhua WEI ¹Zhiyong MA¹

作者信息

1. Department of Internal Medicine,The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China
2. Department of Respiratory Medicine,The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450000,China
折叠

摘要

关键词

Lung neoplasms/EGFR mutation/Concomitant genetic alteration/Targeted therapy/Chemotherapy

分类

医药卫生

引用本文复制引用

Guowei ZHANG,Ruirui CHENG,Yuanyuan NIU,Huijuan WANG,Xiangtao YAN,Mina ZHANG,Xiaojuan ZHANG,Jinpo YANG,Chunhua WEI,Zhiyong MA..Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations[J].中国肺癌杂志,2022,25(9):P.651-657,7.

中国肺癌杂志

OA北大核心CSCDCSTPCDMEDLINE

ISSN：1009-3419

访问量2

下载量0

段落导航